Role of Prostaglandins and Non-steroid Anti-inflammatory Drugs in the Pathogenicity of Vaccinia Virus Free

Abstract

SUMMARY

The effect of prostaglandins (PGs) of the A series (A and dimethyl PGA), E, D, F and PGI (prostacyclin) and of inhibitors of PG synthesis (aspirin and indomethacin) on the pathogenicity of vaccinia virus was studied in BALB/c mice. PGs of the A series, D and F conferred little or no protection to mice against the lethal effects of vaccinia virus. Mice treated with PGE showed a dramatic increase in mortality after viral infection. However, when mice were treated with PGI, their survival was greatly enhanced. Mice treated with aspirin and indomethacin showed a marked increase in mortality. Increased mortality correlated with higher virus yields in target tissues (spleen) and with inhibition of antibody response, whereas the increase in survival correlated with lower virus yields and with normal antibody responses. The significance of our findings is that PGI can block the outcome of the disease caused by vaccinia virus whereas other PGs and their inhibitors not only worsen the disease, but may activate and enhance viral infections through immune suppression.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-68-2-593
1987-02-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/68/2/JV0680020593.html?itemId=/content/journal/jgv/10.1099/0022-1317-68-2-593&mimeType=html&fmt=ahah

References

  1. Benavente J., Esteban M., Jaffe B. M., Santoro M. G. 1984; Selective inhibition of viral gene expression as the mechanism of the antiviral action of PGA1 in vaccinia virus-infected cells. Journal of General Virology 65:599–608
    [Google Scholar]
  2. Braun W., Ishizuka M. 1971; Antibody formation: reduced responses after administration of excessive amounts of non-specific stimulators. Proceedings of the National Academy of Sciences, U.S.A 68:1114–1116
    [Google Scholar]
  3. Burch J. W., Baenziger N. L., Stanford N., Majerus P. W. 1978; Sensitivity of fatty acid cyclooxygenase from human aorta to acetylation by aspirin. Proceedings of the National Academy of Sciences, U.S.A 75:5181–5184
    [Google Scholar]
  4. Ceuppens J. L., Goodwin J. S. 1982; Endogenous prostaglandin E2 enhances polyclonal immunoglobulin production by tonically inhibiting T suppressor cell activity. Cellular Immunology 70:41–48
    [Google Scholar]
  5. Eldor A., Fridman R., Vlodavsky I., Hyam E., Fuks Z., Panet A. 1984; Interferon enhances prostacyclin production by cultured vascular endothelial cells. Journal of Clinical Investigation 73:251–257
    [Google Scholar]
  6. Ersten W., Emre R., Caudar A. D. 1980; An in vitro study on the effect of prostaglandins E2 and F2 alpha on E-rosette forming activity of normal lymphocytes. Prostaglandins 5:255–258
    [Google Scholar]
  7. Giron D. J. 1982; Inhibition of viral replication in cell cultures treated with prostaglandin E1. Proceedings of the Society for Experimental Biology and Medicine 170:25–28
    [Google Scholar]
  8. Goodwin J. S., Ceuppens J. L. 1983; Effect of non-steroidal anti-inflammatory drugs in immune function. Seminars in Arthritis and Rheumatism 13:134–143
    [Google Scholar]
  9. Goodwin J. S., Messner R. p., Peake G. T. 1978a; Inhibitors of T-cell mitogenesis: effect of mitogen dose. Cellular Immunology 45:303–308
    [Google Scholar]
  10. Goodwin J. S., Selinger D. S., Messner R. P., Reed W. P. 1978b; Effect of indomethacin in vivo on humoral and cellular immunity in humans. Infection and Immunity 19:430–433
    [Google Scholar]
  11. Gordon D., Bray M., Morley J. 1976; Control of lymphokine secretion by prostaglandins. Nature; London: 262401–402
    [Google Scholar]
  12. Halpin T. J., Holtzhawer F. J., Campbell R. J., Hall L. J., Correa-Villasenor A., Lanese R., Rice J., Hurwitz E. S. 1982; Reye’s syndrome and medication use. Journal of the American Medical Association 248:687–691
    [Google Scholar]
  13. Harbour D. A., Blyth W. A., Hill T. J. 1978; Prostaglandins enhance spread of herpes simplex virus in cell cultures. Journal of General Virology 41:87–95
    [Google Scholar]
  14. Jaffe E. A., Weksler B. B. 1979; Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin. Journal of Clinical Investigation 63:532–535
    [Google Scholar]
  15. Kuzimiera D., Grinwich K. D., Plescia O. J. 1977; Tumor-mediated immunosuppression: prevention by inhibitors of prostaglandin synthesis. Prostaglandins 14:1175–1182
    [Google Scholar]
  16. Luczak M., Gumulka W., Szwigielski S., Korbecki M. 1975; Inhibition of multiplication of parainfluenza 3 virus in prostaglandin-treated Wish cells. Archives of Virology 49:377–380
    [Google Scholar]
  17. Marcus A. J. 1977; Aspirin and thromboembolism. A possible dilemma. New England Journal of Medicine 297:1284–1285
    [Google Scholar]
  18. Masotti G., Galanti G., Pogesi L., Abbate R., Meriserneri G. G. 1979; Differential inhibition of prostacyclin production and platelet aggregation by aspirin. Lancet ii:1213–1216
    [Google Scholar]
  19. Morito T., Bankhurst A. D., Williams R. C. 1980; Studies on the modulation of immunoglobulin production by prostaglandins. Prostaglandins 20:383–390
    [Google Scholar]
  20. Moss B. 1985; Replication of poxviruses. In Virology pp. 685–703 Fields B. N. Edited by New York: Raven Press;
    [Google Scholar]
  21. Mukherjee P. K., Simpson R. W. 1984; Indomethacin inhibits viral RNA and protein synthesis in cells infected with vesicular stomatitis virus. Virology 140:188–191
    [Google Scholar]
  22. Rappaport R. S., Dodge G. R. 1982; Prostaglandin E. inhibits the production of human interleukin 2. Journal of Experimental Medicine 155:943–948
    [Google Scholar]
  23. Santoro M. G., Benedetto A., Garruba G., Garaci E., Jaffe B. M. 1980; Prostaglandin A compounds as antiviral agents. Science 209:1032–1034
    [Google Scholar]
  24. Santoro M. G., Jaffe B. M., Garaci E., Esteban M. 1982; Antiviral effect of prostaglandins of the A series; inhibition of vaccinia virus replication in cultured cells. Journal of General Virology 63:435–440
    [Google Scholar]
  25. Santoro M. G., Jaffe B. M., Esteban M. 1983; Prostaglandin A inhibits the replication of vesicular stomatitis virus: effect on virus glycoprotein. Journal of General Virology 64:2797–2801
    [Google Scholar]
  26. Snyder D. S., Beller D. I., Unanue E. R. 1982; Prostaglandins modulate macrophage la expression. Nature; London: 299163–165
    [Google Scholar]
  27. Starko K. M., Ray C. G., Dominguez L. B., Stromberg W. L., Woodall D. F. 1980; Reye’s syndrome and salicylate use. Pediatrics 66:859–864
    [Google Scholar]
  28. Stehle R. G. 1982; Physical chemistry, stability and handling of prostaglandins E2, F, D2 and I2: a critical summary. Methods in Enzymology 86:436–458
    [Google Scholar]
  29. Waldman R. J., Hall W. N., McGee H., Van Amburg G. 1982; Aspirin as a risk factor in Reye’s syndrome. Journal of the American Medical Association 247:3089–3094
    [Google Scholar]
  30. Walz-Cicconi M. A., Weller T. H. 1984; Dose-related effect of acetylsalicylic acid on replication of varicella zoster virus in vitro. Proceedings of the National Academy of Sciences, U.S.A 81:5223–5226
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-68-2-593
Loading
/content/journal/jgv/10.1099/0022-1317-68-2-593
Loading

Data & Media loading...

Most cited Most Cited RSS feed